NCT03918031

Brief Summary

This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and distress tolerance. The PFI will focus on feedback about smoking behavior, distress tolerance, and adaptive coping strategies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 17, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

July 15, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 24, 2021

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

November 15, 2024

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

2.3 years

First QC Date

February 15, 2019

Results QC Date

January 18, 2023

Last Update Submit

November 12, 2024

Conditions

Keywords

Psychological DistressTobaccoSmokingFeedbackStressAnxiety DisordersDepression

Outcome Measures

Primary Outcomes (6)

  • Rulers for Smoking Cessation

    The Rulers for Smoking Cessation asks participants to rate three rulers associated with motivation, confidence, and intention to quit smoking. Motivation is indexed by, "How important is stopping smoking to you (0 = Not important at all; 10 = Most important goal of my life)?" with a higher score indicating a better outcome. Confidence is indexed by, "How confident are you that you will quit smoking within the next month (0 = Not at all; 10 = 100% confident)?" with a higher score indicating a better outcome. Intention is indexed by, "How ready are you to quit smoking within the next month (0 = Not at all; 10 = 100% ready)?" with a higher score indicating a better outcome.

    Baseline, 2-week, and 1-month follow-up

  • Barriers to Cessation Scale

    The Barriers to Cessation Scale assesses 19-barriers, or specific stressors, associated with smoking cessation. Participants indicate, according to a 4-point Likert-style scale (0 = Not a barrier to 3 = Large barrier), the extent to which they identify with each of the barriers to cessation. Lower scores indicate a better outcome (range = 0 - 57).

    Baseline, 2-week, and 1-month follow-up

  • Timeline Follow-Back

    The Timeline Follow-Back (TLFB) is a self-report measure to assess retrospective estimates of daily smoking. The TLFB was used to assess smoking rate computed as a mean score of past 7-day cigarettes smoked per day.

    Baseline, 2-week, and 1-month follow-up

  • Distress Tolerance Scale

    The Distress Tolerance Scale is a self-report measure in which respondents indicate, on a 5-point Likert-type scale (1 = 'strongly agree' to 5 = 'strongly disagree'), the extent to which they believe they can experience and withstand distressing emotional states. All items are averaged to create a total mean score ranging from 1 to 5 with higher total scores indicating a better outcome (i.e., greater tolerance for distress).

    Baseline, 2-week, and 1-month follow-up

  • Mood and Anxiety Symptom Questionnaire-Short Form

    The Mood and Anxiety Symptom Questionnaire-Short Form will be used to assess anxiety/depressive symptoms. Participants indicate how much they have experienced each symptom on a 5-point Likert-type scale (1 = Not at all to 5 = Extremely). Specifically, the Anxious Arousal subscale will be used to measure anxiety and the Anhedonic Depression subscale will be used to measure depression. The Anxious Arousal subscale consists of 17-items with lower scores indicating better outcomes (range = 17 - 85). The Anhedonic Depression subscale consists of 22-items with lower scores indicating better outcomes (range = 22 - 110).

    Baseline, 2-week, and 1-month follow-up

  • Self-Help Scale

    The Self-Help Scale asks participants to indicate whether they would be willing to try each of 10 strategies to help deal with depression and anxiety on a 5-point Likert-type scale from 0 (definitely not) to 4 (extremely willing). Higher scores indicate a better outcome (range = 0 - 4).

    Baseline, 2-week, and 1-month follow-up

Study Arms (2)

PFI for Smoking & Distress Tolerance

ACTIVE COMPARATOR

A brief, one-session computer-delivered personalized feedback intervention (PFI) that addresses smoking and distress tolerance.

Behavioral: PFI for Smoking & Distress Tolerance

PFI for Smoking Only

ACTIVE COMPARATOR

A brief, one-session computer-delivered personalized feedback intervention (PFI) that addresses smoking only (no distress tolerance component).

Behavioral: PFI for Smoking Only

Interventions

Personalized Feedback Intervention for smoking and distress tolerance.

PFI for Smoking & Distress Tolerance

Personalized Feedback Intervention for smoking only (no distress tolerance component)

PFI for Smoking Only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Low distress tolerance defined as a DTS mean score of 2.56 or lower
  • Daily smoking for at least one year (minimum 5 cigarettes per day and biochemically confirmed via Carbon Monoxide \[CO\] analysis at least 5 ppm)

You may not qualify if:

  • Currently engaging in treatment for an alcohol/drug problem including smoking cessation
  • Legal status that will interfere with participating
  • Not being fluent in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anxiety and Health Research Laboratory and Substance Use Treatment Clinic, University of Houston

Houston, Texas, 77204, United States

Location

Related Links

MeSH Terms

Conditions

Anxiety DisordersDepressionTobacco Use DisorderTobacco SmokingCigarette SmokingSmoking

Interventions

Smoking Devices

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorSubstance-Related DisordersChemically-Induced DisordersTobacco Use

Intervention Hierarchy (Ancestors)

Manufactured MaterialsTechnology, Industry, and Agriculture

Results Point of Contact

Title
Brooke Kauffman
Organization
University of Houston

Study Officials

  • Brooke Kauffman, M.A.

    University of Houston

    PRINCIPAL INVESTIGATOR
  • Michael Zvolensky, Ph.D.

    University of Houston

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: If participant meets eligibility criteria, the participant will be randomly assigned to complete a one-session computer-delivered intervention: either (1) personalized feedback intervention on ability to handle discomfort and smoking or (2) personalized feedback intervention on smoking only.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 15, 2019

First Posted

April 17, 2019

Study Start

July 15, 2019

Primary Completion

October 24, 2021

Study Completion

October 24, 2021

Last Updated

November 15, 2024

Results First Posted

November 15, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations